Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689956 · ClinicalTrials.gov registry record
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
A clinical trial of FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma and FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 212
- Enrollment target
- 20
- Study locations
NCT06689956 is a study of FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma and FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 212 participants, above the 170-participant average among 5 other FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma trials with a reported enrollment target (25% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT06689956, a study of FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma and FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 212 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (20)
Other
- Medical University of Vienna - Vienna
- AC Camargo Cancer Center - São Paulo
- Institut Universitaire du Cancer Toulouse Oncopole - Toulouse
- University Hospital Essen - Essen
- Meir Medical Center, Faculty of Medicine - Tel-Aviv University - Kefar Sava
- Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale - Naples
- Hospital Materno Infantil Las Palmas - Las Palmas
- Hospital Universitario La Paz - Madrid
- Ospedale Regionale di Lugano, Civico - Lugano
MI
- Fondazione IRCCS Istituto Nazionale Tumori - Milan
- European Institute of Oncology - Milan
Minnesota
- Mayo Clinic in Rochester - Rochester
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- Houston Methodist Hospital - Houston
Ontario
- Sunnybrook Health Sciences, University of Toronto - Toronto
Quebec
- Hopital Maisonneuve Rosemont - Montreal
CN
- Ospedale Michele e Pietro Ferrero - Verduno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2029-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06689956
The ClinicalTrials.gov registry entry for NCT06689956 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 170-participant average among 5 other FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma trials with a reported enrollment target (25% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06689956 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, MI, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06689956 about?
NCT06689956 is a clinical study titled "Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study". This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.
What is the current status of trial NCT06689956?
This trial is currently recruiting. The enrollment target is 212 participants. The study started on 2024-12-04. Estimated completion is 2029-10-31.
What conditions does trial NCT06689956 study?
This clinical trial studies the following conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023.
What interventions are being tested in trial NCT06689956?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06689956?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06689956 being conducted?
This trial has 20 study locations across Minnesota, New York, Texas, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
ACTIVE NOT RECRUITING · Phase 2
-
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
ACTIVE NOT RECRUITING
-
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
ACTIVE NOT RECRUITING · Phase 1
-
Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
All registered trials for this condition
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.